It is widely held that although obesity and type 2 diabetes are polyge
nic in origin, the primary defect causing both conditions is insulin r
esistance? which in turn gives rise to a constellation of other abnorm
alities, including hyperinsulinemia, dyslipidemia, glucose intolerance
, and (in the genetically predisposed) frank hyperglycemia. Explored h
ere is an alternative, albeit speculative, scenario in which hyperinsu
linemia and insulin resistance arise either simultaneously or sequenti
ally from some preexisting defect within the leptin signaling pathway.
Ln either case? a central component of the model is that the breakdow
n of glucose homeostasis that is characteristic of the condition of ob
esity with type 2 diabetes is secondary to disturbances in lipid dynam
ics. The possibility is raised that abnormally high concentrations of
malonyl-CoA in liver and skeletal muscle suppress the activity of mito
chondrial carnitine palmi toyltransferase I and thus fatty acid oxidat
ion in both sites. It is suggested that the buildup of fat within the
muscle cell (caused in part by excessive delivery of VLDLs from the li
ver) interferes with glucose transport or metabolism or both, producin
g insulin resistance. Elevated circulating concentrations of fatty aci
ds are also implicated in the etiology of type 2 diabetes by virtue of
1) their powerful acute insulinotropic effect, 2) their ability to ex
acerbate insulin resistance in muscle, and 3) their long-term detrimen
tal action on pancreatic beta-cell function.